

	Company registration number:	05604462






NOVOCARE LTD

REPORT OF THE DIRECTORS' AND

FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 December 2024



NOVOCARE LTD

BALANCE SHEET

AS AT 31 December 2024


		2024		2023
	Notes	£	£	£	£

FIXED ASSETS
Intangible assets	3		1		1
Tangible assets	4		2,475,266		2,461,906

			2,475,267		2,461,907

CURRENT ASSETS
Debtors		1,293,474		15,000
Cash at bank and in hand		1,147,770		1,877,084

		2,441,244		1,892,084

CREDITORS
Amounts falling due within one year		(1,053,159)		(345,498)

NET CURRENT ASSETS			1,388,085		1,546,586

TOTAL ASSETS LESS
CURRENT LIABILITIES			3,863,352		4,008,493

Creditors falling due after one year			(519,406)		(498,629)


NET ASSETS			3,343,946		3,509,864



CAPITAL AND RESERVES
Called-up equity share capital			5,000		5,500
Other Reserves			5,000		4,500
Profit and loss account			3,333,946		3,499,864

SHAREHOLDERS FUNDS			3,343,946		3,509,864


For the year ending 31 December 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.


The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of the accounts.


All the members have consented to the preparation of abridged financial statements for the year ended 31 December 2024 in accordance with Section 444(2A) of the Companies Act 2006.


The profit and loss account has not been delivered to the Registrar of Companies in accordance with the special provisions applicable to companies subject to the small companies' regime.


These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006. Approved by the board of directors on 4 September 2025 and signed on its behalf.



..........................................................................
Dr K K Malhotra

4 September 2025
The annexed notes form part of these financial statements.

NOVOCARE LTD

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2024

Accounting policies

Statement of compliance

These financial statements have been prepared in accordance with the provisions of Section 1A 'Small entities' of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006. There were no material departures from the standard.

Basis of preparing the financial statements

The financial statements have been prepared under the historical cost convention in accordance with the accounting policies set out below. These financial statements have been prepared in accordance with FRS102 Section 1A - The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.

Turnover

Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts.

Intangible Assets

Goodwill is the difference between the amount paid on the acquisition of a business and the aggregate fair value of its separable net assets. It is being written off in equal annual instalments over its estimated economic life.

Fixed Assets

Tangible fixed assets are stated at cost less depreciation Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following bases: Fixtures and fittings 25% reducing balance basis

Employees

The average number of persons employed by the company (including directors) during the year was 56.



3.	Intangible fixed assets
		Total

	Cost
	At start of period	499,999
	At end of period	499,999

	Amortisation
	At start of period	499,998
	At end of period	499,998

	Net Book Values
	At start of period	1
	At end of period	1



4.	Tangible fixed assets

		Total

	Cost
	At start of period	2,544,434
	Additions	31,068
	At end of period	2,575,502

	Depreciation
	At start of period	82,528
	Provided during the period	17,708
	At end of period	100,236

	Net Book Value
	At start of period	2,461,906
	At end of period	2,475,266

Pension costs

The company operates a defined benefit scheme for its directors and senior employees. The assets of the scheme are held seperately from those of the company in an independently administered fund.